A new plasma biomarker that distinguishes the three proteins of TB from HCs and ORD was discovered by proteomics combined with clinical verification, and provided help for a wider diagnosis of TB
A new plasma biomarker that identifies TB with HCs and ORD proteins is clinically validated using proteomics in combination with proteomics and helps with a wider range of TB diagnostics
A new plasma biomarker for the identification of TB from HCS and ord proteins was found by proteomics combined with clinical validation, which will help to diagnose TB more widely<br>